Kuiper H
Flevoziekenhuis, afd. Neurologie, Hospitaalweg 1, 1315 RA Almere.
Ned Tijdschr Geneeskd. 2004 Apr 3;148(14):670-3.
To determine the clinical spectrum and incidence of neuroborreliosis in the Netherlands.
Retrospective.
All neurological practices in 106 hospital locations in the Netherlands were asked to look for patients with the codes 'other neurological infections' or 'Borrelia burgdorferi' in their Diagnosis & Treatment Combinations registration or the Neurological Coding System, respectively, concerning the year 2001, then to identify the patients with neuroborreliosis and to send a copy of the correspondence with the family doctor and the laboratory data on these patients, after making them anonymous, for data extraction. Pleocytosis in the cerebrospinal fluid combined with a positive test for IgM or IgG antibodies of B. burgdorferi in the serum or cerebrospinal fluid was used as the criterion for the diagnosis neuroborreliosis.
Forty-seven (44%) neurological practices did not respond and twenty-two (21%) either did not use any kind of diagnosis registration system or linkage between the registration and the patient file was impossible. Of the 37 (35%) neurological practices that provided information, 17 had diagnosed neuroborreliosis in 30 patients, 20 of whom met the specified criteria. Fifteen (75%) patients had a radiculopathy, 8 (40%) a peripheral facial palsy and 3 (15%) a myelopathy.
The clinical spectrum of patients with neuroborreliosis was consistent with that described in Denmark. The incidence of neuroborreliosis found was 3.6 per million inhabitants. The real incidence was probably higher because the registration systems used allowed patients with neuroborreliosis to be booked under other (symptomatic) diagnostic codes, paediatricians were not involved in the study, and relatively few participating neurologists practiced in high-risk areas for tick bites and erythema migrans. The low incidence of neuroborreliosis in combination with a high background level of seropositivity in the population implies a low predictive value of positive Borrelia serology. It is therefore essential that when neuroborreliosis is suspected, the cerebrospinal fluid should always be investigated.
确定荷兰神经型莱姆病的临床症状范围及发病率。
回顾性研究。
要求荷兰106家医院的所有神经科门诊,分别在其诊断与治疗组合登记系统或神经编码系统中查找2001年诊断为“其他神经感染”或“伯氏疏螺旋体”的患者,然后确定神经型莱姆病患者,并在对患者信息进行匿名处理后,发送与家庭医生的通信副本及这些患者的实验室数据,以供数据提取。脑脊液中细胞增多,同时血清或脑脊液中伯氏疏螺旋体IgM或IgG抗体检测呈阳性,作为诊断神经型莱姆病的标准。
47家(44%)神经科门诊未回复,22家(21%)要么未使用任何诊断登记系统,要么无法将登记信息与患者病历关联。在提供信息的37家(35%)神经科门诊中,17家诊断出30例神经型莱姆病患者,其中20例符合指定标准。15例(75%)患者患有神经根病,8例(40%)患有周围性面瘫,3例(15%)患有脊髓病。
神经型莱姆病患者的临床症状范围与丹麦所描述的一致。所发现的神经型莱姆病发病率为每百万居民3.6例。实际发病率可能更高,因为所使用的登记系统允许神经型莱姆病患者被登记在其他(有症状的)诊断代码下,儿科医生未参与该研究,且参与研究的神经科医生中,在蜱叮咬和游走性红斑高风险地区执业的相对较少。神经型莱姆病发病率低,而人群中血清阳性背景水平高,这意味着伯氏疏螺旋体血清学阳性的预测价值较低。因此,当怀疑患有神经型莱姆病时,务必始终对脑脊液进行检查。